Review paper
Photodynamic Therapy and Immune Checkpoint Blockade†
Abstract
Immune checkpoints including PD-1 and CTLA-4 help to regulate the intensity and timeframe of the immune response. Since they become upregulated in cancer and prevent sufficient antitumor immunity, monoclonal antibodies against these checkpoints have shown clinical promise for a range of cancers. Multimodal treatment plans combining immune checkpoint inhibitors with other therapies, including photodynamic therapy (PDT), may help to expand...
Paper Details
Title
Photodynamic Therapy and Immune Checkpoint Blockade†
Published Date
Jun 23, 2020
Volume
96
Issue
5
Pages
954 - 961